The Corporate Advisory Board (CAB) was developed to identify important issues and ideas for collaborative programs related to reproductive and sexual health care. The CAB is an independent membership organization managed by ARHP and comprised of industry representatives. CAB dues benefit the Fund for the Future of Reproductive Health which provides seed money to develop innovative projects and programs to support reproductive health education and advocacy efforts for the next generation.
Members of the CAB include:
- Bayer HealthCare Pharmaceuticals
- Duramed Pharmaceuticals, Inc., a subsidiary of Barr Pharmaceuticals, Inc.
- Eli Lilly & Company
- Endo Pharmaceuticals
- Ferring Pharmaceuticals
- GlaxoSmithKline
- Hologic LP
- Merck & Company, Inc.
- Ortho Women’s Health & Urology
- PathNet Esoteric Laboratories, Inc.
- QIAGEN, Inc.
- Schering-Plough
- Solvay Pharmaceuticals, Inc.
- Wyeth
Current as of July 2008
For more information or to join the CAB, please contact Shana Brown, ARHP development manager, at sbrown@arhp.org or (202) 466-3825.
